Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ran Laiso"'
Autor:
TO. Conceição, LGS. Cabral, MG. Laveli-Silva, JC. Pacheco, MG. Alves, DC. Rabelo, RAN. Laiso, DA. Maria
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss , Pp 112054- (2021)
The main obstacle in the treatment of cancer patients has been resistance to multiple drugs, leading to the need to develop molecules with a higher specificity target. The liposomal formulation DODAC/2-AEH2P has antitumor potential, inducing apoptosi
Externí odkaz:
https://doaj.org/article/fcead2b78a054295a3cde6e23ac00360
Autor:
D C Rabelo, Durvanei Augusto Maria, M G Laveli-Silva, Lgs Cabral, J C Pacheco, Monique Gonçalves Alves, Ran Laiso, Thais de Oliveira Conceição
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 112054-(2021)
The main obstacle in the treatment of cancer patients has been resistance to multiple drugs, leading to the need to develop molecules with a higher specificity target. The liposomal formulation DODAC/2-AEH2P has antitumor potential, inducing apoptosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a3530b84cddadaf730bfb1fff501c2
http://www.sciencedirect.com/science/article/pii/S0753332221008374
http://www.sciencedirect.com/science/article/pii/S0753332221008374
Autor:
T O, Conceição, Lgs, Cabral, M G, Laveli-Silva, J C, Pacheco, M G, Alves, D C, Rabelo, Ran, Laiso, D A, Maria
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 142
The main obstacle in the treatment of cancer patients has been resistance to multiple drugs, leading to the need to develop molecules with a higher specificity target. The liposomal formulation DODAC/2-AEH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5535956989d129acec2e8e2985044331
https://pubmed.ncbi.nlm.nih.gov/34463267
https://pubmed.ncbi.nlm.nih.gov/34463267